Moody's Gives Negative View On Pharma Credit
Moody's: credit ratings for drugmakers could be hurt as industry copes with expiring patents
01:15PM 11/19/09
Ex-pharma Executive Runs As Dem For Kan. Governor
Former pharmaceutical executive forms to run as Democrat for Kansas governor
11:33AM 11/18/09
Another Genzyme Drug Goes Kaboom: BioBuzz
Company halts development of kidney disease drug following poor test results.
08:05AM 11/18/09
Vivus Seeks Faster ED Drug: Biobuzz
Company says ED drug met all goals in phase III study.
06:42AM 11/18/09
Practicing Balance With P&G: China Watch
By Stephanie Link | By Brittany Umar
NEW YORK -- Stephanie Link, director of research for Action Alerts PLUS, explains why she is still such a fan of Procter & Gamble and why this stock could be a perfect balance for your China portfolio.
05:00AM 11/09/09
Stock Picks for the Defensive Investor (RealMoney.com $)
In light of investor wariness, here are a few stocks that fit Graham's defensive approach.
02:30PM 11/03/09
Evan Bayh: Hypocrisy on the Public Option
Sen. Evan Bayh's wife Susan (left) sits on the board of WellPoint. She and the company stand to benefit if the public option on health care fails.
06:45AM 10/29/09
Evan Bayh: Hypocrisy on the Public Option (RealMoney.com $)
The senator's wife sits on the board of WellPoint, which will benefit if the public option fails.
03:57PM 10/28/09
Gauging the Health of This Biotech (Deep in the Money Calls $)
Concerns about this company's drugs are likely to be balanced out by its positive earnings report.
09:45AM 10/28/09
A Look at Johnson & Johnson: Mad About Options
The Mad About Options crew reviews recent comments on Johnson & Johnson - Ticker JNJN - and offers options strategies for traders and investors.
08:00AM 10/28/09
'Fast Money' Recap: Bullish on Amazon
The trading panel was amazed at the stock's results and price action.
08:14PM 10/22/09
'Mad Money Lightning Round': Gilead's Great
Cramer says investors will be rewarded with their patience in the stock.
07:23PM 10/22/09
Cramer's 'Mad Money' Recap: Truly Great CEOs (Final)
Cramer says top-flight CEOs such as Steve Jobs, Alan Mulally and Mickey Drexler have transformed their companies. Click for news from Jim Cramer.
06:34PM 10/22/09



Connect with TheStreet